Insiders who reported open-market trades in the last 12 months at the companies Robin Kramer files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Priya Singhal - $666K in BIIB purchases and sales in the last 12 months
Lloyd Minor - $240K in BIIB purchases and sales in the last 12 months
Nicole Murphy - $585 in BIIB purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Robin Kramer is a corporate insider, tracked as Director of Armata Pharmaceuticals, Inc. (ARMP). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Robin Kramer last file a Form 4?
The most recent primary Form 4 on record is dated 12 March 2026, one of 4 filings going back to 2024.
InsiderAlpha's records for Robin Kramer go back to 2024: 4 primary Form 4 filings, an average of 1.3 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
